Factors Predisposing to the Unplanned Hospital Readmission (UHR) in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma (OSCC): Experience from a Tertiary Cancer Centre
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s13193-020-01135-1.pdf
Reference21 articles.
1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2018) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953
2. Rochefort MM, Tomlinson JS (2012) Unexpected readmissions after major cancer surgery: an evaluation of readmissions as a quality-of-care indicator. Surg Oncol Clin N Am 21(3):397–405
3. Landrum L, Weinrich S (2006) Readmission data for outcomes measurement: identifying and strengthening the empirical base. Qual Manag Health Care 15(2):83–95
4. Haneuse S, Dominici F, Normand SL, Schrag D (2018) Assessment of between-hospital variation in readmission and mortality after Cancer surgical procedures. JAMA Netw Open 1(6):e183038
5. Graboyes EM, Zenga J, Nussenbaum B (2017) Head & neck reconstruction: Predictors of readmission. Oral Oncol 74:159–162
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oral cavity squamous cell carcinoma and readmission: rates, causes, and risk factors;2024-02-14
2. Identification and preliminary study of a novel interacting protein SCRIB with fibroblast activation protein in OSCC;Acta Biochimica et Biophysica Sinica;2023-06-19
3. Impact of surgical site infection on unplanned hospital readmissions, initiation of adjuvant treatment following surgery, and disease‐free survival on patients with upper aerodigestive tract squamous cell carcinoma;Journal of Surgical Oncology;2023-05-26
4. Utility of topical tranexamic acid in head-and-neck cancer surgery: A myth or reality?;Cancer Research, Statistics, and Treatment;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3